ASPSW

On January 16, 2026, the Client Accounts sold an aggregate of 2,108 shares of Common Stock (which represents 0.018% of the outstanding shares of Common Stock). The Reporting Person intends to evaluate on an ongoing basis its investment in the Issuer and its options with respect to such investment. Depending on market conditions, an evaluation of the business and the prospect of the Issuer and other factors, the Reporting Person may, in its sole discretion, purchase additional shares of Common Stock, or other securities convertible into or exchangeable for shares of Common Stock, and/or other equity, debt, notes instruments or other securities of the Issuer, dispose of shares of Common Stock or such other securities from time to time in the open market, in privately negotiated transactions or otherwise, and/or otherwise change its intention with respect to any and all matters referred to in this Item 4. Except as set forth herein, the Reporting Person does not have, as of the date of this Schedule 13D, any plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Person reserves the right to adopt such plans or proposals in the future, subject to applicable regulatory requirements, if any.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The response to Item 3 of this Amendment No. 10 is incorporated by reference herein.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The response to Item 3 of this Amendment No. 10 is incorporated by reference herein.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The response to Item 3 of this Amendment No. 10 is incorporated by reference herein.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The response to Item 3 of this Amendment No. 10 is incorporated by reference herein.